Does the SANO trial really move us toward organ preservation for esophageal cancer?

Sheraz R. Markar; Mark Van Berge Henegouwen; Christiane Bruns; Lorenzo Ferri; Richard Van Hillegersberg; Wayne Hofstetter; Magnus Nilsson

doi:10.1093/dote/doaf049

Does the SANO trial really move us toward organ preservation for esophageal cancer?

Sheraz R. Markar
, Mark Van Berge Henegouwen
, Christiane Bruns
, Lorenzo Ferri
, Richard Van Hillegersberg
, Wayne Hofstetter
, Magnus Nilsson^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Article number	doaf049
Journal	Diseases of the Esophagus
Volume	38
Issue number	3
DOIs	https://doi.org/10.1093/dote/doaf049
Publication status	Published - Jun 2025

Access to Document

10.1093/dote/doaf049

doaf049Final published version, 235 KBLicence: Taverne

Cite this

@article{20d17f44e7504e31890bda759085349e,

title = "Does the SANO trial really move us toward organ preservation for esophageal cancer?",

author = "Markar, \{Sheraz R.\} and \{Van Berge Henegouwen\}, Mark and Christiane Bruns and Lorenzo Ferri and \{Van Hillegersberg\}, Richard and Wayne Hofstetter and Magnus Nilsson",

year = "2025",

month = jun,

doi = "10.1093/dote/doaf049",

language = "English",

volume = "38",

journal = "Diseases of the Esophagus",

issn = "1120-8694",